AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23128768 — intervention group
Group type: EXPERIMENTAL
Intervention: Introduction of Solids intervention
Number of subjects: 0
Study 23128768 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study 23128768 — intervention group
Group type: COMPARATOR
Intervention: No interventions
Number of subjects: 0
Study 20506674 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) 100 mg per day from day 3 to day 7 of the cycle
Number of subjects: 19
Study 20506674 — intervention group
Group type: COMPARATOR
Intervention: Letrozole 2.5 mg per day on the same cycle days
Number of subjects: 19
Study 20506674 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC)
Number of subjects: 19
Study 20506674 — intervention group
Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 19
Study 17109725 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoadsorption (IA) with protein A; N = 5
Number of subjects: 10
Study 17109725 — intervention group
Group type: COMPARATOR
Intervention: Control group (no immunoadsorption); N = 5
Number of subjects: 10
Study 15640336 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 500 microg b.i.d. for 2 weeks
Number of subjects: 135
Study 15640336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 15640336 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) in nonsmokers
Number of subjects: 135
Study 11966868 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 1 g b.i.d. plus tetracycline 500 mg q.i.d. with lansoprazole 30 mg b.i.d. for 7 days (group LAT)
Number of subjects: 270
Study 11966868 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 1 g b.i.d. plus tetracycline 500 mg q.i.d. with ranitidine bismuth citrate 400 mg b.i.d. for 7 days (group RBCAT)
Number of subjects: 270
Study 11966868 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 1 g b.i.d. plus doxycycline 100 mg b.i.d. and lansoprazole 30 mg b.i.d. for 14 days (group LAD)
Number of subjects: 270
Study 9918267 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic quality of life measures (NHP and RAQOL)
Number of subjects: 40
Study 7772357 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine (S) 1 mg/kg
Number of subjects: 24
Study 7772357 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium (R) 600 mcg/kg
Number of subjects: 24
Study 7772357 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium (R) 150 mcg/kg (open label)
Number of subjects: 24
Study 2278610 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous N-acetylcysteine (NAC)
Number of subjects: 0
Study 2278610 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 341951 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin (500 mg four times daily)
Number of subjects: 0
Study 341951 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (500 mg four times daily)
Number of subjects: 0
Study 341951 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin with sulphametopyrazine (1 g at start of exacerbation followed by erythromycin 500 mg four times daily)
Number of subjects: 0
Study 341951 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin alone
Number of subjects: 0
Study 341951 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 0
Study 341951 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin plus sulphametopyrazine
Number of subjects: 0
Study 30466880 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization tests on micro-level data
Number of subjects: 0
Study 28792952 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/day (after crossover from placebo)
Number of subjects: 112
Study 28792952 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 112
Study 26680412 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloader brace
Number of subjects: 18
Study 26680412 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 18
Study 22725971 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (1-hour sessions, totaling 36 sessions over 12 weeks)
Number of subjects: 19
Study 22725971 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 19
Study 22725971 — intervention group
Group type: COMPARATOR
Intervention: Eutrophic group (EG)
Number of subjects: 19
Study 20723885 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupported online CCBT
Number of subjects: 303
Study 20723885 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 303
Study 20723885 — intervention group
Group type: COMPARATOR
Intervention: CCBT and TAU combined
Number of subjects: 303
Study 19523672 — intervention group
Group type: EXPERIMENTAL
Intervention: Timothy extract monotherapy (19 microg Phl p 5 daily)
Number of subjects: 54
Study 19523672 — intervention group
Group type: EXPERIMENTAL
Intervention: Timothy extract plus 9 additional pollen extracts
Number of subjects: 54
Study 19523672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 17058921 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen application in mastoidectomy (22 cases, 22 ears)
Number of subjects: 41
Study 17058921 — intervention group
Group type: COMPARATOR
Intervention: No collagen application in mastoidectomy (19 cases, 19 ears)
Number of subjects: 41
Study 14746626 — intervention group
Group type: EXPERIMENTAL
Intervention: Special silk clothes (MICROAIR DermaSilk) worn for a week
Number of subjects: 46
Study 14746626 — intervention group
Group type: COMPARATOR
Intervention: Cotton clothing (control group)
Number of subjects: 46
Study 11700495 — intervention group
Group type: EXPERIMENTAL
Intervention: SCD Response System
Number of subjects: 20
Study 11700495 — intervention group
Group type: COMPARATOR
Intervention: SCD Sequel System
Number of subjects: 20
Study 9407153 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold of 10,000 platelets per cubic millimeter
Number of subjects: 255
Study 9407153 — intervention group
Group type: COMPARATOR
Intervention: Threshold of 20,000 platelets per cubic millimeter
Number of subjects: 255
Study 9407153 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 255
Study 7517135 — intervention group
Group type: EXPERIMENTAL
Intervention: Woman-made erotic film
Number of subjects: 47
Study 7517135 — intervention group
Group type: COMPARATOR
Intervention: Man-made erotic film
Number of subjects: 47
Study 7517135 — intervention group
Group type: EXPERIMENTAL
Intervention: Both films
Number of subjects: 47
Study 3497039 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg tenoxicam
Number of subjects: 12
Study 3497039 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg tenoxicam
Number of subjects: 12
Study 3497039 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg tenoxicam
Number of subjects: 12
Study 29962227 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance and gait exercises (10 weeks, three times/week)
Number of subjects: 100
Study 29962227 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 100
Study 28274268 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture + metformin placebo
Number of subjects: 342
Study 28274268 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture + metformin
Number of subjects: 342
Study 28274268 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture + metformin placebo
Number of subjects: 342
Study 28274268 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 342
Study 28274268 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 342
Study 26158468 — intervention group
Group type: EXPERIMENTAL
Intervention: Low attentional load task
Number of subjects: 0
Study 26158468 — intervention group
Group type: EXPERIMENTAL
Intervention: High attentional load task
Number of subjects: 0
Study 26158468 — intervention group
Group type: EXPERIMENTAL
Intervention: Appetitive solutions (juice)
Number of subjects: 0
Study 26158468 — intervention group
Group type: EXPERIMENTAL
Intervention: Aversive solutions (quinine)
Number of subjects: 0
Study 24146762 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus (SIR)
Number of subjects: 60
Study 24146762 — intervention group
Group type: COMPARATOR
Intervention: CNI
Number of subjects: 60
Study 20031956 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone (2.5 mg per patch)
Number of subjects: 12
Study 18400322 — intervention group
Group type: EXPERIMENTAL
Intervention: Group treatment program following the cognitive orientation to daily occupational performance (CO-OP) approach
Number of subjects: 43
Study 15881046 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Orientation to daily Occupational Performance (CO‐OP)
Number of subjects: 18
Study 15881046 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18
Study 12832240 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/day)
Number of subjects: 251
Study 12832240 — intervention group
Group type: COMPARATOR
Intervention: Divalproex (500-2500 mg/day)
Number of subjects: 251
Study 10830644 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐min open suction method
Number of subjects: 16
Study 10830644 — intervention group
Group type: COMPARATOR
Intervention: 10‐min spit method
Number of subjects: 16
Study 10830644 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐min closed suction method
Number of subjects: 16
Study 10830644 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction machine (general preference)
Number of subjects: 16
Study 8898260 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with SLI
Number of subjects: 0
Study 8898260 — intervention group
Group type: COMPARATOR
Intervention: Delay interval before naming
Number of subjects: 0
Study 8898260 — intervention group
Group type: COMPARATOR
Intervention: Duration of prime exposure before naming
Number of subjects: 0
Study 8898260 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup of children with expressive but not receptive skills
Number of subjects: 0
Study 8898260 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup of children with both expressive and receptive language problems
Number of subjects: 0
Study 1514669 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (800 micrograms b.d.)
Number of subjects: 36
Study 1514669 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (750 micrograms b.d.)
Number of subjects: 36
Study 1514669 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide and Beclomethasone dipropionate
Number of subjects: 36
Study 6469823 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced erythrocythemia (334 ml of red blood cells)
Number of subjects: 9
Study 6469823 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 9
Study 29974643 — intervention group
Group type: EXPERIMENTAL
Intervention: 595-nm pulsed dye laser (PDL)
Number of subjects: 20
Study 29974643 — intervention group
Group type: COMPARATOR
Intervention: fractional 532-nm KTP laser
Number of subjects: 20
Study 30032504 — intervention group
Group type: COMPARATOR
Intervention: PEEP: 0 cmH(2)O
Number of subjects: 60
Study 30032504 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP: 10 cmH(2)O
Number of subjects: 60
Study 30032504 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP: 15 cmH(2)O
Number of subjects: 60
Study 26816292 — intervention group
Group type: EXPERIMENTAL
Intervention: Dojo (biofeedback video game)
Number of subjects: 138
Study 26816292 — intervention group
Group type: COMPARATOR
Intervention: Rayman 2: The Great Escape (control game)
Number of subjects: 138
Study 24188509 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 301
Study 22280502 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Preventive Treatment in infants with Sulfadoxine‐Pyrimethamine (IPTi‐SP)
Number of subjects: 0
Study 22280502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22280502 — intervention group
Group type: EXPERIMENTAL
Intervention: IPTi‐SP
Number of subjects: 0
Study 19394499 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 39
Study 19394499 — intervention group
Group type: COMPARATOR
Intervention: Sham Electroacupuncture (SEA)
Number of subjects: 39
Study 19394499 — intervention group
Group type: COMPARATOR
Intervention: Advice and Exercise (A&E)
Number of subjects: 39
Study 17443923 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliable Change Index (RCI) with constant correction for practice effects
Number of subjects: 160
Study 17443923 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard RCI without correction for practice
Number of subjects: 160
Study 17443923 — intervention group
Group type: EXPERIMENTAL
Intervention: Within-subject standard deviation (WSD) as an error estimate
Number of subjects: 160
Study 16254575 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report questionnaire comprising socio‐demographic variables, dietary habits, physical activity in the home, at work and recreation
Number of subjects: 387
Study 12030736 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 18 microg b.i.d.
Number of subjects: 692
Study 12030736 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 9 microg b.i.d.
Number of subjects: 692
Study 12030736 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 4.5 microg b.i.d. and higher
Number of subjects: 692
Study 12030736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 692
Study 12030736 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (all doses)
Number of subjects: 692
Study 10065517 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral flexion-extension radiographs
Number of subjects: 36
Study 7727666 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laboratory‐based reporting system
Number of subjects: 0
Study 7727666 — intervention group
Group type: COMPARATOR
Intervention: Passive reporting system
Number of subjects: 0
Study 2039070 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational rating system using job titles and an arbitrary numeric scale
Number of subjects: 50
Study 2039070 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational rating system using specific criteria for rating job functions
Number of subjects: 50
Study 2039070 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective and valid rating format
Number of subjects: 50
Study 2039070 — intervention group
Group type: EXPERIMENTAL
Intervention: Rating system developed
Number of subjects: 50
Study 7239397 — intervention group
Group type: EXPERIMENTAL
Intervention: Lonazolac‐Ca
Number of subjects: 20
Study 7239397 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac‐Na
Number of subjects: 20
Study 31805985 — intervention group
Group type: EXPERIMENTAL
Intervention: Solar-powered oxygen (SPO2) delivery system
Number of subjects: 2400
Study 31805985 — intervention group
Group type: COMPARATOR
Intervention: Standard of care oxygen delivery (without SPO2)
Number of subjects: 2400
Study 31805985 — intervention group
Group type: EXPERIMENTAL
Intervention: SPO2 system functionality, safety, efficacy, operating costs, nursing knowledge, skills, and retention for oxygen administration
Number of subjects: 2400
Study 29309483 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-TEAM program (supervised administration of preventive asthma medication at school and 3 school-based telemedicine visits)
Number of subjects: 400
Study 29309483 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (control group)
Number of subjects: 400
Study 29309483 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-TEAM program
Number of subjects: 400
Study 26926910 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) plus Treatment as Usual (TAU) - up to 12 one-hour weekly sessions.
Number of subjects: 240
Study 26926910 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) alone.
Number of subjects: 240
Study 24436135 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (memantine + donepezil)
Number of subjects: 37
Study 24436135 — intervention group
Group type: COMPARATOR
Intervention: Control group (donepezil only)
Number of subjects: 37
Study 23202836 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead exposure in males (6.8 ± 2.0 µg/dL)
Number of subjects: 108
Study 23202836 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead exposure in females (5.9 ± 1.9 µg/dL)
Number of subjects: 108
Study 23202836 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower socioeconomic status and well water use
Number of subjects: 108
Study 23202836 — intervention group
Group type: EXPERIMENTAL
Intervention: Well water use
Number of subjects: 108
Study 23202836 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with BPb concentrations of 10 µg/dL or above
Number of subjects: 108
Study 19060628 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg immediate-release fluvastatin twice daily (b.i.d.)
Number of subjects: 27
Study 19060628 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg extended-release fluvastatin daily
Number of subjects: 27
Study 19060628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 18090187 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedication with diazepam 5-10 mg
Number of subjects: 760
Study 15144039 — intervention group
Group type: COMPARATOR
Intervention: Influenza vaccine (group A)
Number of subjects: 232
Study 15144039 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza and pneumococcus vaccines simultaneously (group B)
Number of subjects: 232
Study 11228086 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate aerosol (1.25 mg upon arrival and a second dose 15 minutes later if needed)
Number of subjects: 60
Study 11228086 — intervention group
Group type: COMPARATOR
Intervention: Sublingual isosorbide dinitrate (5 mg tablet)
Number of subjects: 60
Study 9972670 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of methimazole (MMI) and 20 g of colestipol‐hydrochloride (COL) daily
Number of subjects: 92
Study 9972670 — intervention group
Group type: COMPARATOR
Intervention: 30 mg of MMI daily
Number of subjects: 92
Study 9972670 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of MMI and 20 g of COL daily
Number of subjects: 92
Study 8054260 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium pidolate 4.5 g/d for one month
Number of subjects: 43
Study 8054260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 3175536 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (Bay g 5421)
Number of subjects: 11
Study 3175536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 1106807 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexon (polyglycolic acid) sutures
Number of subjects: 104
Study 1106807 — intervention group
Group type: COMPARATOR
Intervention: Silk sutures
Number of subjects: 104
Study 1106807 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene sutures
Number of subjects: 104
Study 1106807 — intervention group
Group type: COMPARATOR
Intervention: Nylon sutures
Number of subjects: 104
Study 31068018 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined passive head-up and -down movement with device-guided slow breathing
Number of subjects: 14
Study 31068018 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 14
Study 28974570 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow sodium (200 mmol/d)
Number of subjects: 48
Study 28974570 — intervention group
Group type: COMPARATOR
Intervention: Placebo (70 mmol sodium/d)
Number of subjects: 48
Study 28974570 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 48
Study 26698878 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 3 × 400 mg for three days
Number of subjects: 494
Study 26698878 — intervention group
Group type: COMPARATOR
Intervention: Fosfomycin 3 g (single dose) for three days
Number of subjects: 494
Study 22886633 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 184
Study 22886633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study 21193696 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented intensity postinduction intensification (PII)
Number of subjects: 272
Study 21193696 — intervention group
Group type: COMPARATOR
Intervention: Standard intensity postinduction intensification (PII)
Number of subjects: 272
Study 18714245 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic Bands (EBG)
Number of subjects: 45
Study 18714245 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Machines (WMG)
Number of subjects: 45
Study 18714245 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 45
Study 17201265 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuanju compound capsule combined with erogenous focus exercise
Number of subjects: 52
Study 17201265 — intervention group
Group type: COMPARATOR
Intervention: Erogenous focus exercise alone (Control)
Number of subjects: 52
Study 12559215 — intervention group
Group type: COMPARATOR
Intervention: Furosemide withdrawal
Number of subjects: 29
Study 12559215 — intervention group
Group type: COMPARATOR
Intervention: Continuing furosemide
Number of subjects: 29
Study 10690863 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 IU/day recombinant human FSH (Puregon)
Number of subjects: 38
Study 10690863 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 IU/day recombinant human FSH (Puregon)
Number of subjects: 38
Study 9068529 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary estradiol
Number of subjects: 0
Study 9068529 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 8446138 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (120 to 360 mg per day)
Number of subjects: 1292
Study 8446138 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (25 to 100 mg per day)
Number of subjects: 1292
Study 8446138 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.2 to 0.6 mg per day)
Number of subjects: 1292
Study 8446138 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (12.5 to 50 mg per day)
Number of subjects: 1292